TY - JOUR KW - Autoimmunity KW - Humans KW - leprosy KW - Melanocytes KW - Melanoma KW - Skin KW - Symbiosis KW - Vitiligo AU - Das P K AU - Wijngaard R M AU - Wankowicz-Kalinska A AU - Le Poole I C AB -

Vitiligo is a skin disease in which melanocytes (MCs) are eradicated from lesional epidermis, resulting in disfiguring loss of pigment. MCs are destroyed by MC-reactive T cells, as well as other non-immune and immune components. Similarities exist between the autoimmunity observed in vitiligo and the tumour immunity observed in melanoma immuno-surveillance. An analysis of these mechanisms might lead to the development of new therapies for both vitiligo and melanoma.

BT - Trends in immunology C1 - http://www.ncbi.nlm.nih.gov/pubmed/11286727?dopt=Abstract DA - 2001 Mar IS - 3 J2 - Trends Immunol. LA - eng N2 -

Vitiligo is a skin disease in which melanocytes (MCs) are eradicated from lesional epidermis, resulting in disfiguring loss of pigment. MCs are destroyed by MC-reactive T cells, as well as other non-immune and immune components. Similarities exist between the autoimmunity observed in vitiligo and the tumour immunity observed in melanoma immuno-surveillance. An analysis of these mechanisms might lead to the development of new therapies for both vitiligo and melanoma.

PY - 2001 SP - 130 EP - 6 T2 - Trends in immunology TI - A symbiotic concept of autoimmunity and tumour immunity: lessons from vitiligo. VL - 22 SN - 1471-4906 ER -